Stay updated on Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial

Sign up to get notified when there's something new on the Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T08:46:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T09:22:15.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A newer revision, v3.7.0, was added to the record history, replacing the previous v3.6.6 entry and signaling an update to the study record.
    Difference
    0.1%
    Check dated 2026-09-20T12:16:02.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry v3.6.6, and the previous revision v3.6.5 has been removed from the visible history.
    Difference
    0.1%
    Check dated 2026-08-30T12:12:30.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The study record history now shows a new revision entry for Revision: v3.6.5, superseding the previous v3.6.4. This indicates a small update to the revision metadata rather than a substantive change to the record content.
    Difference
    0.1%
    Check dated 2026-08-09T11:29:23.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4 in the page’s revision history, reflecting the latest platform update for this study record. This indicates a backend change to the ClinicalTrials.gov page without altering the study data displayed.
    Difference
    0.1%
    Check dated 2026-07-26T10:37:44.000Z thumbnail image

Stay in the know with updates to Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aripiprazole Lauroxil in Schizophrenia Relapse Prevention Clinical Trial page.